This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Almac House. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Colin Roderick O'Dowd: Innovator in Cancer Treatment
Introduction
Colin Roderick O'Dowd is a notable inventor based in Craigavon, Armagh, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatments. His innovative work has led to the creation of a patent that addresses critical medical needs.
Latest Patents
O'Dowd holds a patent for "Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors." This invention relates to compounds that inhibit the activity of Wee-1 kinase, which plays a crucial role in cell cycle regulation. The patent also encompasses pharmaceutical compositions that include these compounds and outlines methods for using them in cancer treatment.
Career Highlights
Throughout his career, Colin Roderick O'Dowd has worked with prominent organizations, including Almac House and Almac Discovery Limited. His experience in these companies has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.
Collaborations
O'Dowd has collaborated with various professionals in his field, including his coworker Graham Trevitt. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Colin Roderick O'Dowd is a distinguished inventor whose work in developing cancer treatment solutions has made a significant impact. His patent for Wee-1 kinase inhibitors exemplifies his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile